MedPath

ALTI-TRIAZOLAM TAB 0.125MG

ALTI-TRIAZOLAM TAB 0.125MG

Discontinued
DIN Number

00614351

Drug Class

Human

Market Date

Dec 31, 1987

Company
HC

altimed pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00614351
AIG Number0112970001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD05 TRIAZOLAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRIAZOLAMActive
Strength: .125 MG / TAB
Monograph: TRIAZOLAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.